{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:04:26Z","timestamp":1790240666582,"version":"4.1.0"},"reference-count":20,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wenzhou Basic Public Welfare Research Project","award":["Y20220358"],"award-info":[{"award-number":["Y20220358"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Fecal occult blood testing (FOBT) is a cornerstone of colorectal cancer (CRC) screening. The current quantitative FOBTs, however, were centralized, which limited their accessibility in preliminary screening implemented by community health. This study aimed to establish a rapid, highly sensitive quantitative FOB-detection method based on near-infrared fluorescence immunochromatography, hereinafter referred to as point-of-care fecal immunochemical testing (POCT-FIT), and to evaluate its performance against a centralized testing system in population-based CRC screening. Methods: Anti-human hemoglobin monoclonal antibodies were labeled with near-infrared fluorescent nanospheres (excitation 770 nm; emission 794 nm), and FOB test strips were prepared using immunochromatography. A fluorescence immunochromatography analyzer was used to scan the fluorescence intensities of the test line (T) and control line (C). The ratio of the fluorescence intensity on the T-line to that on the C one (T\/C) was calculated at different hemoglobin concentrations, and a standard curve was generated over the span of 50 to 2000 ng\/mL. A total of 115 clinical fecal samples were collected for methodological comparison with the commercially available OC-Sensor system (Eiken Chemical Co., Ltd., Tokyo, Japan). In a non-paired CRC screening program implemented by community health in Wenzhou, 3163 participants were assigned to the centralized testing group (OC-Sensor system) and 5211 participants to the POCT-FIT group (near-infrared fluorescence immunochromatography method). A positive threshold was set up at 100 ng\/mL. Colonoscopy and histopathological results served as the gold standard. Results: The testing results of the two groups for the 115 samples showed that there is a strong linear correlation (R = 0.9959) and good agreement between the two methods. In the screening of community health, CRC prevalence was 2.78% (88\/3163) in the centralized group (OC-Sensor) and 1.00% (52\/5211) in the decentralized one (POCT-FIT). Sensitivities for CRC were 98.9% (95% CI: 95.8\u201399.9%) and 100% (95% CI: 93.2\u2013100%), respectively, with no statistically significant difference; specificities were 29.2% (95% CI: 27.6\u201330.8%) and 27.3% (95% CI: 26.1\u201328.5%), with the centralized group being slightly higher (p = 0.001). Positive and negative likelihood ratios were comparable between the two methods. Conclusions: The sensitivity of the POCT-FIT method was comparable to that of the OC-Sensor method, and its negative results were associated with a lower probability of missed CRC, which may help reduce medical insurance expenditure for CRC treatment. POCT-FIT is simple to operate and portable, and the price of the disposable immunochromatographic test strip is much lower than that of the turbidimetric method (centralized testing system). Thus, it meets the practical needs of settings with low daily testing numbers (such as preliminary community health or resource-limited and sparsely populated areas) and serves as an effective complement to centralized testing.<\/jats:p>","DOI":"10.3390\/diagnostics16193087","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:06:37Z","timestamp":1790237197000},"page":"3087","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Application of a Quantitative POCT-FIT Based on Near-Infrared Fluorescence Immunochromatography in Population-Based Colorectal Cancer Screening: A Comparative Evaluation with a Centralized Testing System"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4619-4640","authenticated-orcid":false,"given":"Fang-Chao","family":"Zhu","sequence":"first","affiliation":[{"name":"Wenzhou Central Hospital, Wenzhou 325000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lin","family":"Ku","sequence":"additional","affiliation":[{"name":"Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou 325000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Pan","sequence":"additional","affiliation":[{"name":"Wenzhou Central Hospital, Wenzhou 325000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Guang","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Infectious Disease Traceability, Early Warning and Intelligent Decision-Making, National Institute for Viral Disease Control and Prevention, China CDC, Beijing 100052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Gen","family":"Shu","sequence":"additional","affiliation":[{"name":"Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou 325000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"Interpretation of the 2020 Global Cancer Statistics Report","volume":"7","author":"Liu","year":"2021","journal-title":"J. Multidiscip. Cancer Manag. Electron."},{"key":"ref_2","first-page":"372","article-title":"Chinese expert consensus on laboratory diagnostic techniques for early colorectal cancer and precancerous lesions","volume":"44","author":"Zheng","year":"2021","journal-title":"Chin. J. Lab. Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"US Preventive Services Task Force (2021). Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA, 325, 1965\u20131977.","DOI":"10.1001\/jama.2021.6238"},{"key":"ref_4","unstructured":"Early Diagnosis and Treatment Group, Oncology Branch, and Chinese Medical Association (2023). Chinese guidelines for colorectal cancer screening and early diagnosis and treatment (2023 edition). Natl. Med. J. China, 103, 2827\u20132847."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2188\/jea.JE20210057","article-title":"Effectiveness of screening using fecal occult blood testing and colonoscopy on the risk of colorectal cancer: The Japan Public Health Center-based Prospective Study","volume":"33","author":"Tanaka","year":"2023","journal-title":"J. Epidemiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/gutjnl-2022-327188","article-title":"Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model","volume":"72","author":"Meester","year":"2023","journal-title":"Gut"},{"key":"ref_7","first-page":"1304","article-title":"Experimental evaluation and influencing factors of three fecal occult blood reagents","volume":"9","author":"Lin","year":"2012","journal-title":"Lab. Med. Clin."},{"key":"ref_8","first-page":"CD009276","article-title":"Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals","volume":"6","author":"Grobbee","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"18841","DOI":"10.1038\/s41598-026-46337-9","article-title":"Head-to-head comparison of fecal occult blood tests for colorectal neoplasia detection in Chinese outpatients: A multicenter diagnostic trial","volume":"16","author":"Duan","year":"2026","journal-title":"Sci. Rep."},{"key":"ref_10","first-page":"287","article-title":"Comparison of quantitative and qualitative fecal occult blood testing in organized colorectal cancer screening","volume":"33","author":"Zhu","year":"2024","journal-title":"Chin. J. Cancer"},{"key":"ref_11","first-page":"747","article-title":"Comparison of quantitative fecal occult blood testing instrument and colloidal gold test strip for population-based colorectal cancer screening","volume":"47","author":"Huang","year":"2013","journal-title":"Chin. J. Lab. Med."},{"key":"ref_12","unstructured":"National Institute for Health and Care Excellence (2023). Quantitative Faecal Immunochemical Testing to Guide Colorectal Cancer Pathway Referral in Primary Care [DG56], NICE."},{"key":"ref_13","first-page":"426","article-title":"A new method for blood NT-proBNP determination based on a near-infrared point of care testing device with high sensitivity and wide scope","volume":"30","author":"Zhang","year":"2017","journal-title":"Biomed. Environ. Sci."},{"key":"ref_14","first-page":"174","article-title":"A new method for ultra-sensitive P24 antigen assay based on near-infrared fluorescent microsphere immunochromatography","volume":"33","author":"Wang","year":"2020","journal-title":"Biomed. Environ. Sci."},{"key":"ref_15","first-page":"1068","article-title":"Development of a rapid detection reagent for creatine kinase isoenzyme CK-MB","volume":"43","author":"Zeng","year":"2017","journal-title":"J. Beijing Univ. Technol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/096228029900800204","article-title":"Measuring agreement in method comparison studies","volume":"8","author":"Bland","year":"1999","journal-title":"Stat. Methods Med. Res."},{"key":"ref_17","first-page":"114","article-title":"Effectiveness of colonoscopy, fecal immunochemical testing, and risk-stratified screening strategies in colorectal cancer screening: A multicenter randomized controlled trial","volume":"14","author":"Chen","year":"2023","journal-title":"Med. J. Peking Union Med. Coll. Hosp."},{"key":"ref_18","first-page":"114","article-title":"Evaluation of quantitative and qualitative fecal occult blood reagents in colorectal cancer screening","volume":"34","author":"Shen","year":"2014","journal-title":"Chin. J. Dig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S2468-1253(24)00222-X","article-title":"Computer-aided diagnosis for the resect-and-discard strategy for colorectal polyps: A systematic review and meta-analysis","volume":"9","author":"Hassan","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.7326\/M24-0080","article-title":"Comparative performance of common fecal immunochemical tests: A cross-sectional study","volume":"177","author":"Levy","year":"2024","journal-title":"Ann. Intern. Med."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/19\/3087\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:24:26Z","timestamp":1790238266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/19\/3087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":20,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["diagnostics16193087"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16193087","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}